Case Details
- Citation: [2020] SGCA 7
- Title: Liberty Sky Investments Ltd v Aesthetic Medical Partners Pte Ltd and other appeals and another matter
- Court: Court of Appeal of the Republic of Singapore
- Date of Decision: 10 February 2020
- Judges (Coram): Andrew Phang Leong JA; Judith Prakash JA; Belinda Ang Saw Ean J
- Case Numbers: Civil Appeals Nos 55, 56 and 57 of 2019 and Civil Appeal Summons No 100 of 2019
- Parties: Liberty Sky Investments Limited (Appellant/Applicant) v Aesthetic Medical Partners Pte Ltd and Dr Goh Seng Heng (Respondents/Other parties)
- Procedural Posture: Appeals from the High Court decisions reported at [2019] SGHC 39 and [2019] SGHC 40
- Legal Areas: Contract (misrepresentation; formation); Equity (remedies—rescission; bar to rescission); Civil procedure (pleadings; leave to adduce fresh evidence)
- Plaintiff/Applicant: Liberty Sky Investments Ltd (“LSI”)
- Defendant/Respondent: Aesthetic Medical Partners Pte Ltd (“AMP”) and Dr Goh Seng Heng (“Goh”), with other related matters on appeal
- Counsel: Nehal Harpreet Singh SC and team (for appellant in CA 55 and 56 and respondent in CA 57); Lok Vi Ming SC and team (for respondent in CA 56 and SUM 100 and appellant in CA 57); Narayanan Sreenivasan SC and Rajaram Muralli Raja (for respondent in CA 55)
- Judgment Length: 10 pages; 5,967 words
- Statutes Referenced: Evidence Act (as indicated in metadata)
- Key Issues Framed in the Judgment: Fraudulent misrepresentation; inducement; rescission and restitution; equitable bars to rescission; sufficiency of pleadings; leave to adduce fresh evidence
Summary
In Liberty Sky Investments Ltd v Aesthetic Medical Partners Pte Ltd ([2020] SGCA 7), the Court of Appeal dismissed three related civil appeals and an application for leave to adduce further evidence. The dispute arose from a share purchase transaction in which Liberty Sky Investments Ltd (“LSI”), an investment vehicle, entered into a sale and purchase agreement (“SPA”) with Dr Goh Seng Heng (“Goh”) to acquire shares in Aesthetic Medical Partners Pte Ltd (“AMP”). LSI alleged that Goh had fraudulently misrepresented that AMP’s shares would soon be sold in a trade sale to a prominent Singapore buyer and, failing that, that AMP would be listed via an initial public offering (“IPO”) within a targeted timeframe.
The Court of Appeal upheld the High Court’s findings that the trade sale and IPO representations were false and were made fraudulently. It further affirmed the High Court’s approach to remedies: LSI was not granted rescission because it failed to establish that substantial restitution in integrum was possible. On the procedural side, the Court of Appeal also rejected LSI’s attempt to reframe its case on appeal and refused to allow a new argument that had not been pleaded or properly introduced. The Court of Appeal’s decision underscores both substantive principles governing fraudulent misrepresentation and the strict discipline of pleadings and appellate procedure in Singapore civil litigation.
What Were the Facts of This Case?
Dr Goh Seng Heng founded AMP in 2008. LSI, incorporated in the Seychelles, was an investment vehicle controlled by Gong Ruilin (“Gong”), who was LSI’s sole director and shareholder. Gong’s husband, Lin Lijun (“Lin”), acted as LSI’s representative in the transaction. The transaction in question was a share acquisition: on 25 November 2014, LSI executed an SPA with Goh to purchase 32,049 shares in AMP for a purchase price of $14,422,050.
Because the parties needed to conclude the deal quickly, Gong and Lin did not conduct due diligence on AMP. Instead, they sought contractual protection in the form of a guarantee of their investment capital and an internal rate of return (“IRR”) of 15% per annum. The “Guarantee” was represented to be something AMP would provide. This background is important because the case turned on what induced LSI to enter the SPA: whether the key driver was the promised guarantee/IRR, or whether fraudulent statements about a near-term liquidity event (trade sale or IPO) played a real and substantial role.
LSI’s pleaded case was that Goh made two categories of fraudulent misrepresentations. First, Goh allegedly represented that there would be a trade sale of all AMP shares to an important person in Singapore—specifically, a billionaire named Peter Lim—asserting that the trade sale had a 99% chance of being concluded, was likely, imminent, and would occur within one month or very soon (the “Trade Sale Representations”). Second, Goh allegedly represented that if the trade sale did not materialise, he intended to list AMP through an IPO on the Singapore Exchange targeted for completion around March to June 2015 (the “IPO Representations”).
According to the judgment, the relevant fraudulent misrepresentations were made over dinner on 23 October 2014 and at a meeting on 24 October 2014 (the “24 October 2014 Meeting”). After the SPA was executed, LSI sold 30,549 AMP shares to two Chinese investors at the same price LSI paid Goh, leaving LSI with a beneficial interest in only 1,500 AMP shares. Neither the trade sale nor the IPO occurred. Gong and Lin then brought claims against Goh and AMP in two suits: Suit 1311 (2015) for fraudulent misrepresentation, and Suit 457 (2017) for the purchase price plus 15% IRR under the Guarantee.
What Were the Key Legal Issues?
The Court of Appeal had to address, first, whether the High Court was correct in finding that Goh was liable for fraudulent misrepresentation. This required the court to assess whether the Trade Sale and IPO Representations were false, whether Goh made them fraudulently, and whether those representations played a real and substantial part in inducing Gong and Lin (and thus LSI) to enter into the SPA.
Second, the appeals raised issues about remedies for fraudulent misrepresentation, particularly rescission. The High Court had refused rescission on the basis that LSI failed to show that substantial restitution in integrum was possible. The Court of Appeal therefore had to consider the legal framework for rescission and the equitable bars to rescission, including how the burden of proof operates and what is required to demonstrate the feasibility of restitution.
Third, the Court of Appeal had to deal with procedural matters. In CA 56, LSI attempted to pivot its case on appeal by advancing a “new argument” about rescission in its personal capacity, tied to the claim that there had never been a sale of the AMP shares to the Chinese investors under the investment agreements. The court also had to consider whether such a new argument could be entertained given pleading requirements and the rules on introducing new matters on appeal. Finally, SUM 100 concerned LSI’s application for leave to adduce fresh evidence in the form of affidavits from the Chinese investors, which was relevant to the alternative “trustee” theory of restitution.
How Did the Court Analyse the Issues?
On fraudulent misrepresentation (CA 57), the Court of Appeal approached the matter as a question of fact and evaluation of evidence. It held that the High Court had rightly concluded—based on a comprehensive evaluation of objective evidence—that the Trade Sale and IPO Representations were false and that Goh made them fraudulently. The court rejected Goh’s attempt to narrow the representations by arguing that he only mentioned “Peter Lim” after the SPA was executed, and that therefore LSI could not rely on the Trade Sale Representations.
The Court of Appeal found Goh’s argument unpersuasive and “literalist”. Even if Peter Lim’s name was not repeated in later correspondence, that did not necessarily mean it was not uttered at the 24 October 2014 Meeting. The court relied on subsequent conduct and documentary evidence: Gong informed Lin on WeChat that Peter Lim was the prospective buyer shortly after the 24 October 2014 Meeting, which would not have been possible if Gong had not heard the name from Goh. The court also noted that Goh had admitted in his further and better particulars that at the 24 October 2014 Meeting he had informed Gong that Nelson Loh (a director of AMP) was negotiating a trade sale to Thomson Medical and/or Peter Lim. The Court of Appeal emphasised that Goh was represented by counsel throughout and was unlikely to have made mistakes in the contents of his pleaded particulars.
Crucially, the Court of Appeal also addressed the legal sufficiency of the misrepresentation. Even if Goh had not specified Peter Lim as the prospective buyer, he still represented that a trade sale was imminent. The court held that this was sufficient to establish liability for fraudulent misrepresentation. In other words, the actionable misrepresentation did not depend on the precise identity of the counterparty, so long as the representation about imminence and likelihood was made fraudulently and induced the representee.
On inducement, the Court of Appeal rejected the submission that the Guarantee was the real reason LSI entered the SPA. The court reiterated the governing principle that a representation is actionable if it played a real and substantial part in inducing the representee to enter the contract. It cited Panatron Pte Ltd v Lee Cheow Lee [2001] 2 SLR(R) 435 at [23]. Applying this, the court agreed with the High Court that the Trade Sale and IPO Representations played such a part. The court reasoned that Gong and Lin clearly wanted to make a quick and handsome profit from a liquidity event, and the representations were directed to that objective.
Turning to CA 56 and the remedies question, the Court of Appeal addressed LSI’s attempt to obtain rescission or a broader measure of damages. The court noted that LSI had conceded that its “trustee argument” was a fallback. Even so, the court held that the trustee argument would have failed. It was a completely new argument that could not succeed because LSI did not plead that it was suing in a representative capacity as required by the Rules of Court. It also did not apply for leave to introduce the new argument on appeal. The court thus treated the attempt to reconfigure the case as procedurally impermissible and substantively unmeritorious.
In addition, the Court of Appeal explained why the trustee theory lacked merit on the facts. LSI did not enter into the SPA for the benefit of the Chinese investors; the fraudulent misrepresentations were directed only at Gong and Lin. Any trust between LSI and the Chinese investors (if any) would have arisen only after the tort had been committed, because the investment agreements with the Chinese investors were entered into after the SPA. This timing undermined the conceptual basis for claiming rescission and damages in respect of shares held beneficially by the Chinese investors.
Finally, the Court of Appeal dealt with the “pleading issue” raised by LSI. LSI argued that because Goh did not plead any bars to rescission, the impossibility of restitution in integrum should not have been an issue at trial. The Court of Appeal indicated that, as representor, Goh has the legal burden of proving any bars to rescission, referencing authorities including Emile Erlanger and Others v The New Sombrero Phosphate Company and Others (1878) 3 App Cas 1218 and Geoffrey Alan Salt v Stratstone Specialist Limited [2015] EWCA Civ 745. While the excerpt provided is truncated, the Court of Appeal’s approach reflects a careful alignment between equitable principles and the procedural allocation of burdens.
What Was the Outcome?
The Court of Appeal dismissed Civil Appeals Nos 55, 56 and 57 of 2019 and dismissed Civil Appeal Summons No 100 of 2019. In practical terms, this meant that the High Court’s findings on liability for fraudulent misrepresentation were affirmed, and LSI did not obtain rescission. The remedy outcome remained that LSI was entitled only to damages for the 1,500 AMP shares that it beneficially owned, rather than rescission or damages for the full 32,049 shares.
The dismissal of SUM 100 also meant that LSI did not succeed in introducing the Investors’ Affidavits as fresh evidence to support its alternative restitution narrative. The Court of Appeal’s refusal to entertain LSI’s late-stage argumentative shifts further reinforced that litigants must plead their case properly and cannot rely on appellate procedure to cure foundational deficiencies.
Why Does This Case Matter?
Liberty Sky Investments is significant for practitioners because it illustrates how Singapore courts treat fraudulent misrepresentation claims as both fact-intensive and legally structured. The decision confirms that courts will look beyond formalistic arguments about what was said in later documents. Where objective evidence supports that a representation was made at the relevant time, subsequent correspondence that omits a name will not necessarily defeat liability. The case also clarifies that the actionable misrepresentation can be established even if the identity of the counterparty is not precisely repeated later, provided the representation about imminence and likelihood is made fraudulently.
On remedies, the case is a useful authority on rescission and the equitable requirement of restitution in integrum. Even where fraudulent misrepresentation is established, rescission is not automatic. The court’s reasoning shows that the feasibility of restoring parties to their pre-contract position is central. This is particularly relevant in share transactions where the shares may have been transferred to third parties, complicating restitution.
Finally, the decision is a strong reminder of pleading discipline and appellate restraint. LSI’s attempt to pivot from a trustee-based restitution theory to a personal-capacity rescission theory was rejected because it was not pleaded and was not properly introduced on appeal. For litigators, the case underscores that equitable and restitutionary remedies are not only substantive questions but also procedural ones: the court will expect parties to articulate their case early, with the correct capacity and factual basis, and to seek leave where required.
Legislation Referenced
- Evidence Act (as indicated in the case metadata)
- Rules of Court (Cap 322, R 5, 2014 Rev Ed) — specifically provisions on pleadings and leave to introduce new matters on appeal (O 6 r 2(1)(c); O 57 r 9A(4)(b))
Cases Cited
- Panatron Pte Ltd v Lee Cheow Lee [2001] 2 SLR(R) 435
- Emile Erlanger and Others v The New Sombrero Phosphate Company and Others (1878) 3 App Cas 1218
- Geoffrey Alan Salt v Stratstone Specialist Limited t/a Stratstone Cadillac Newcastle [2015] EWCA Civ 745
- [2019] SGHC 39
- [2019] SGHC 40
- [2020] SGCA 7
Source Documents
This article analyses [2020] SGCA 7 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.